KR20240082377A - 펩티드 - Google Patents

펩티드 Download PDF

Info

Publication number
KR20240082377A
KR20240082377A KR1020247013802A KR20247013802A KR20240082377A KR 20240082377 A KR20240082377 A KR 20240082377A KR 1020247013802 A KR1020247013802 A KR 1020247013802A KR 20247013802 A KR20247013802 A KR 20247013802A KR 20240082377 A KR20240082377 A KR 20240082377A
Authority
KR
South Korea
Prior art keywords
peptide
amino acid
tgf
group
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247013802A
Other languages
English (en)
Korean (ko)
Inventor
요시노리 스즈키
마사히코 기네부치
Original Assignee
페프티드림 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 페프티드림 아이엔씨. filed Critical 페프티드림 아이엔씨.
Publication of KR20240082377A publication Critical patent/KR20240082377A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020247013802A 2021-09-30 2022-09-30 펩티드 Pending KR20240082377A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2021-161353 2021-09-30
JP2021161353 2021-09-30
PCT/JP2022/036850 WO2023054712A1 (ja) 2021-09-30 2022-09-30 ペプチド

Publications (1)

Publication Number Publication Date
KR20240082377A true KR20240082377A (ko) 2024-06-10

Family

ID=85780814

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247013802A Pending KR20240082377A (ko) 2021-09-30 2022-09-30 펩티드

Country Status (10)

Country Link
US (1) US20250034212A1 (cg-RX-API-DMAC7.html)
EP (1) EP4410816A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023054712A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240082377A (cg-RX-API-DMAC7.html)
CN (1) CN118103387A (cg-RX-API-DMAC7.html)
AU (1) AU2022355276A1 (cg-RX-API-DMAC7.html)
CA (1) CA3234324A1 (cg-RX-API-DMAC7.html)
IL (1) IL311773A (cg-RX-API-DMAC7.html)
TW (1) TW202334179A (cg-RX-API-DMAC7.html)
WO (1) WO2023054712A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024347940A1 (en) * 2023-09-29 2026-04-30 Peptidream Inc. Peptide
WO2025100520A1 (ja) * 2023-11-10 2025-05-15 ペプチドリーム株式会社 ペプチド、ペプチド複合体、医薬組成物、細胞培養用組成物、及び医療用、診断用又は研究用に用いられる組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066140A1 (en) 2000-03-09 2001-09-13 Genzyme Corporation Use of tgf-beta antagonists to treat or to prevent loss of renal function
WO2012030394A1 (en) 2010-09-01 2012-03-08 Genzyme Corporation Treatment of myocardial infarction using tgf - beta antagonists
WO2015103355A1 (en) 2014-01-01 2015-07-09 Medivation Technologies, Inc. Compounds and methods of use
JP2021100972A (ja) 2018-09-18 2021-07-08 ファイザー・インク がん処置のためのTGFβ阻害剤およびCDK阻害剤の組合せ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
SI1724284T1 (sl) 2000-12-07 2009-12-31 Lilly Co Eli Glp-1 fuzijski proteini
CA2484994C (en) * 2002-04-29 2016-06-14 St. Louis University Peptide antagonists of tgf-beta family members and therapeutic uses thereof
EP1964916B1 (en) 2005-12-06 2012-08-01 The University of Tokyo Multi-purpose acylation catalayst and use thereof
EP2419116A1 (en) * 2009-04-13 2012-02-22 North Western University Novel peptide-based scaffolds for cartilage regeneration and methods for their use
WO2017024407A1 (en) * 2015-08-11 2017-02-16 The Royal Institution For The Advancement Of Learning/Mcgill University Peptidic tgf-beta antagonists
KR102631542B1 (ko) * 2018-03-14 2024-02-01 서울대학교산학협력단 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도
EP4410958A4 (en) * 2021-09-30 2025-11-12 Jsr Corp PROCESS FOR THE PRODUCTION OF ORGANOIDS, CULTURE MEDIUM FOR THE PRODUCTION OF ORGANOIDS, ORGANOID AND PROCESS FOR EVALUATING TEST SUBSTANCE

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066140A1 (en) 2000-03-09 2001-09-13 Genzyme Corporation Use of tgf-beta antagonists to treat or to prevent loss of renal function
WO2012030394A1 (en) 2010-09-01 2012-03-08 Genzyme Corporation Treatment of myocardial infarction using tgf - beta antagonists
WO2015103355A1 (en) 2014-01-01 2015-07-09 Medivation Technologies, Inc. Compounds and methods of use
JP2021100972A (ja) 2018-09-18 2021-07-08 ファイザー・インク がん処置のためのTGFβ阻害剤およびCDK阻害剤の組合せ

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Massague, Nat. Rev. Mol. Cell Biol., 2012 ; 13 (10).
Zhang et al., Cold Spring Harb Perspect Biol. 2017 ; 9 (4).

Also Published As

Publication number Publication date
CA3234324A1 (en) 2023-04-06
TW202334179A (zh) 2023-09-01
AU2022355276A1 (en) 2024-05-16
JPWO2023054712A1 (cg-RX-API-DMAC7.html) 2023-04-06
WO2023054712A1 (ja) 2023-04-06
IL311773A (en) 2024-05-01
CN118103387A (zh) 2024-05-28
EP4410816A4 (en) 2025-11-19
EP4410816A1 (en) 2024-08-07
US20250034212A1 (en) 2025-01-30

Similar Documents

Publication Publication Date Title
CN120118207A (zh) 稳定肽-介导的靶向蛋白降解
JP2019523214A (ja) Mt1−mmpに対して特異的な二環式ペプチド−毒素コンジュゲート
CN115151556A (zh) 人转铁蛋白受体结合肽
EP4410816A1 (en) Peptide
KR20230170918A (ko) 펩티드 및 펩티드를 포함하는 조성물
JP7854211B2 (ja) ヘマグルチニン結合ペプチド
US20180170967A1 (en) Stapled peptides and uses thereof
WO2023022234A1 (ja) ヒトトランスフェリンレセプター結合ペプチド
US20250282820A1 (en) Peptide complex having trkb binding activity
TW202434613A (zh) 人類運鐵蛋白受體結合肽
HK40105341A (en) Human transferrin receptor–binding peptide
AU2024331192A1 (en) Peptide complex having vegfr -2 agonist activity
CN121925425A (zh) 肽
Abujubara Toward the synthesis and characterization of bioactive peptides: Engineering of transmembrane peptide conjugates for targeted drug delivery
KR20250162589A (ko) 호흡기 세포융합 바이러스 표면 당단백질 펩티드, 접합체 및 이의 용도
CA3282856A1 (en) Humantransferrin receptor-binding peptide
CN117858889A (zh) 肽及包含肽的组合物
KR20240045202A (ko) Ghr-결합 펜딩 펩티드 및 이를 포함하는 조성물
HK40057758A (en) Hemagglutinin-binding peptide
HK40057758B (zh) 血球凝集素结合肽
Wen Development and Application of Cell Penetrating Beta-Hairpin and Alpha-Helical Peptides

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240424

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application